Vascular and metabolic effects of angiotensin II receptor blockers

Uricosuric Action of Losartan via the Inhibition of Urate Transporter 1 (URAT 1) in Hypertensive Patients

(2008) T. Hamada et al.   AMERICAN JOURNAL OF HYPERTENSION

Aliskiren

(2008) Morris J. Brown   CIRCULATION

Long-Term Effects of Angiotensin II Receptor Blockade with Valsartan on Carotid Arterial Stiffness and Hemodynamic Alterations in Patients with Essential Hypertension

(2008) Takafumi Okura et al.   CLINICAL AND EXPERIMENTAL HYPERTENSION

Effects of Valsartan or Amlodipine on Endothelial Function and Oxidative Stress after One Year Follow-up in Patients with Essential Hypertension

(2008) Yoshitaka Hirooka et al.   CLINICAL AND EXPERIMENTAL HYPERTENSION

Blocking the renin-angiotensin-aldosterone system to prevent diabetes mellitus

(2008) Darren K McGuire et al.   Diabetes & Vascular Disease Research

Valsartan Improves Arterial Stiffness in Type 2 Diabetes Independently of Blood Pressure Lowering

(2008) Janaka Karalliedde et al.   HYPERTENSION

Candesartan Decreases Carotid Intima-Media Thickness by Enhancing Nitric Oxide and Decreasing Oxidative Stress in Patients with Hypertension

(2008) Hiroyoshi ONO et al.   HYPERTENSION RESEARCH

A One-Year Study of the Antiatherosclerotic Effect of the Angiotensin-II Receptor Blocker Losartan in Hypertensive Patients

(2008) Makoto Sonoda et al.   International Heart Journal

Thrombolytics for PE and right ventricular dysfunction

(2008) Syed Wamique Yusuf et al.   LANCET

Aliskiren Combined with Losartan in Type 2 Diabetes and Nephropathy

(2008) Hans-Henrik Parving et al.   NEW ENGLAND JOURNAL OF MEDICINE

Telmisartan, Ramipril, or Both in Patients at High Risk for Vascular Events

(2008)   NEW ENGLAND JOURNAL OF MEDICINE

Uric Acid and Cardiovascular Risk

(2008) Daniel I. Feig et al.   NEW ENGLAND JOURNAL OF MEDICINE